Literature DB >> 6127157

Dietary orotic acid, a new selective growth stimulus for carcinogen altered hepatocytes in rat.

A Columbano, G M Ledda, P M Rao, S Rajalakshmi, D S Sarma.   

Abstract

It was observed that orotic acid (OA), a precursor for pyrimidine nucleotide biosynthesis, when supplied exogenously at 1% level in the diet selectively stimulated the growth of hepatocytes modified by 1,2-dimethylhydrazine (1,2-DMH) to form gamma-glutamyltransferase (gamma-GT) (EC 2.3.2.2) positive islands. Increasing the duration of OA diet from 5 to 10 weeks resulted in an increase in the number of foci from 6 to 14/cm2. Rats that received the carcinogen and basal diet, however, developed only 1-2 foci/cm2. This unique effect of OA can be further accentuated by supplying a liver cell proliferative stimulus, such as a single necrogenic dose of CCl4.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6127157     DOI: 10.1016/0304-3835(82)90060-x

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  4 in total

Review 1.  Tumor promotion in the liver.

Authors:  R Schulte-Hermann
Journal:  Arch Toxicol       Date:  1985-08       Impact factor: 5.153

2.  Occurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells. A sequential study.

Authors:  A Columbano; G M Ledda-Columbano; P M Rao; S Rajalakshmi; D S Sarma
Journal:  Am J Pathol       Date:  1984-09       Impact factor: 4.307

Review 3.  Compensatory regeneration, mitogen-induced liver growth, and multistage chemical carcinogenesis.

Authors:  G M Ledda-Columbano; P Coni; G Simbula; I Zedda; A Columbano
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

4.  Identification of Circulating Genomic and Metabolic Biomarkers in Intrahepatic Cholangiocarcinoma.

Authors:  Helen Winter; Pamela J Kaisaki; Joe Harvey; Edoardo Giacopuzzi; Matteo P Ferla; Melissa M Pentony; Samantha J L Knight; Ricky A Sharma; Jenny C Taylor; James S O McCullagh
Journal:  Cancers (Basel)       Date:  2019-11-28       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.